Literature DB >> 10752516

Reproductive technologies and risk of ovarian cancer.

K E Wakeley1, E C Grendys.   

Abstract

Use of artificial technologies is increasing within the United States. Unfortunately, data describing the possible effects of 'superovulation' and potential risk of subsequent ovarian carcinoma are not well defined. This discussion focuses on current data regarding the potential for increased risk for ovarian carcinoma in patients who have undergone infertility evaluation and subsequent treatments.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10752516     DOI： 10.1097/00001703-200002000-00008

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN： 1040-872X            Impact factor:   1.927


  3 in total

1.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

Review 2.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2013-08-13

3.  Testicular Busulfan Injection in Mice to Prepare Recipients for Spermatogonial Stem Cell Transplantation Is Safe and Non-Toxic.

Authors:  YuSheng Qin; Ling Liu; YaNan He; Chen Wang; MingYuan Liang; XiaoLi Chen; HaiSheng Hao; Tong Qin; XueMing Zhao; Dong Wang
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.